Atlas Trials

A Double-Blind, Randomized, Dose Response Study of Three Doses of Delavirdine Mesylate (U-90152S) in Combination With Zidovudine (ZDV) Versus ZDV Alone in HIV-1 Infected Individuals With CD4 Counts of 200-500mm3

Clinical trial NCT00002124 · COMPLETED

Trial details

NCT number
NCT00002124
Sponsor
Pharmacia and Upjohn
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
HIV Infections
Enrollment
1250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.